PARSIPPANY, NJ--(Marketwired - May 9, 2013) - The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for RECOTHROM®, Thrombin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results